Enanta Pharma Q4 Loss Narrows

(RTTNews) - Enanta Pharmaceuticals, Inc., (ENTA) Monday said fourth-quarter loss attributable to common stockholders narrowed to $4.4 million or $0.25 per share from $5.38 million or $4.78 per share in the comparable quarter last year.

On average, four analysts polled by Thomson Reuters expected the company to report a loss of $0.29 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues decreased to $1.3 million from $1.9 million last year. Analysts expected revenues of $1.0 million.

Research and development expenses totaled $4.3 million, flat with last year.